Both in Pharmaceuticals
Harmony Biosciences Holdings vs SELLAS Life Sciences Group
Over the past year HRMY returned +46.5% and SLS returned +366.4%; their daily moves had a correlation of 0.14.
HRMY +46.5% SLS +366.4%Growth of $1, one year, split-adjusted
| Metric | HRMY | SLS |
|---|---|---|
| Price | $37.95 | $9.98 |
| Market cap | $2.21B | $2.02B |
| Today | −0.84% | −11.99% |
| 1 month | −11.2% | −13.4% |
| 6 months | +26.5% | +91.2% |
| Year to date | +1.4% | +164.7% |
| 1 year | +42.5% | +357.8% |
| Revenue growth (YoY) | +30.3% | — |
| Gross margin | 75.8% | — |
| Net margin | 28.9% | — |
| P/E (TTM) | 12.2× | — |
| Price / sales | 2.3× | — |
| Net cash | $513.8M | $138.3M |
| Dividend yield | — | — |
| Volatility (60d) | 33.9% | 88.6% |
| Short % of float | 12.1% | 27.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).